DrugPatentWatch Database Preview
Profile for Canada Patent: 2225761
US Patent Family Members and Approved Drugs for Canada Patent: 2225761
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Dec 18, 2022 | Oak Pharms Inc | ZIOPTAN | tafluprost |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |